Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 3,970.00
+60.00 (1.53%)
At close: Nov 3, 2026
| Market Cap | 44.32B -22.1% |
| Revenue (ttm) | 19.60B -16.0% |
| Net Income | 3.07B +45.2% |
| EPS | 272.90 +41.3% |
| Shares Out | 11.16M |
| PE Ratio | 14.55 |
| Forward PE | n/a |
| Dividend | 185.00 (4.66%) |
| Ex-Dividend Date | Sep 29, 2026 |
| Volume | 1,440 |
| Open | 3,905.00 |
| Previous Close | 3,910.00 |
| Day's Range | 3,885.00 - 4,105.00 |
| 52-Week Range | 3,410.00 - 7,690.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |